Journal Title
Targeted Oncology

TARGET ONCOL

ISSN / eISSN
1776-2596 / 1776-260X
Aims and Scope
Targeted Oncology addresses physicians and scientists committed to oncology and cancer research by providing a programme of articles on molecularly targeted pharmacotherapy in oncology. The journal includes:

Original Research Articles on all aspects of molecularly targeted agents for the treatment of cancer, including immune checkpoint inhibitors and related approaches.
Comprehensive narrative Review Articles and shorter Leading Articles discussing relevant clinically established as well as emerging agents and pathways.
Current Opinion articles that place interesting areas in perspective.
Therapy in Practice articles that provide a guide to the optimum management of a condition and highlight practical, clinically relevant considerations and recommendations.
Systematic Reviews that use explicit, systematic methods as outlined by the PRISMA statement.
Adis Drug Reviews of the properties and place in therapy of both newer and established targeted drugs in oncology.
Subject Area

ONCOLOGY

CiteScore
8.40 View Trend
CiteScore Ranking
Category Quartile Rank
Medicine - Pharmacology (medical) Q1 #32/272
Medicine - Oncology Q1 #76/404
Medicine - Cancer Research Q2 #69/230
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2024) Quartile
ONCOLOGY Q2
H-index
35
Country/Area of Publication
FRANCE
Publisher
Springer International Publishing
Publication Frequency
Quarterly
Year Publication Started
2006
Annual Article Volume
70
Open Access
NO
Contact
SPRINGER, VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS, 3311 GZ

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now